3781 results for «2023»

Filter By

3781 results

Interventions with drug-coated balloons – a PCR Statement

18 May 2023

Paris, France, 17 May 2023.  The field of coronary drug-coated balloon (DCB) angioplasty looks set to assume growing importance in the years to come and the potential for increased use of these devices in clinical practice is considerable.

Interventions with drug-coated balloons – a PCR Statement

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes

ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock

27 Aug 2023

Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris

Author

Leonidas Koliastasis
ECLS-SHOCK

Effect of myocardial viability, percutaneous coronary intervention and functional recovery on clinical outcomes in the REVIVED-BCIS2 randomized trial

13 Mar 2023

Dejan Milasinovic provides his take on this clinical trial which was presented by Divaka Perera (London, United Kingdom), at the American College of Cardiology (ACC/WCC) 2023 Scientific Session.

Dejan Milasinovic

Author

Dejan Milasinovic
Effect of myocardial viability, percutaneous coronary intervention and functional recovery on clinical outcomes in the REVIVED-BCIS2 randomized trial

The OCTOBER trial: OCT-guided or angiography-guided PCI in complex bifurcation lesions

29 Aug 2023

Dejan Milasinovic provides his take on the final results of the OCTOBER trial which were presented by Lene Nyhus Andreasen during the ESC 2023 congress in Amsterdam.

Dejan Milasinovic

Author

Dejan Milasinovic
The OCTOBER trial: OCT-guided or angiography-guided PCI in complex bifurcation lesions

Minimally invasive vs conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

07 Mar 2023

Reported from ACC 2023 / WCC

Edoardo Zancanaro provides his take on this clinical trial presented by Enoch Akowuah at the American College of Cardiology Scientific Session (ACC.23/WCC).

Edoardo Zancanaro

Author

Edoardo Zancanaro
Minimally invasive versus conventional sternotomy for mitral valve repair surgery: An expertise based multicentre randomised controlled trial (UK Mini Mitral)

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Contemporary calcium modification strategies for complex calcification, which tools and when?

20 May 2023 – From EuroPCR 2023

Nieves Gonzalo and Jeroen Sonck reflect on the management of calcific disease, one of the hot and trending topics at EuroPCR 2023. They discuss how to prepare before treating, the modalities to evaluate the calcium and how to anticipate the need for more dedicated devices.

Contemporary calcium modification strategies for complex calcification, which tools and when?

"I really think that today it is not possible to avoid women working side by side with men" - An interview with Chiara De Biase

08 Mar 2023

Find out what Chiara De Biase, interventional cardiologist, thinks about the place of women in her profession today, and more broadly in health.

Chiara De Biase

"Women are still underrepresented in research in interventional cardiology" - An interview with Nieves Gonzalo

08 Mar 2023

We asked Nieves Gonzalo to share with us her views as a female interventional cardiologist on the place of women in her profession and in the world of health in general.

Nieves Gonzalo

Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial

02 Mar 2023

Luis Ortega Paz interviews Prof. Sanjit Jolly who presented the prespecified analysis of the randomised UNIVERSAL trial at the CRT meeting which was held on February 25-28, 2023 in Washington, DC, USA.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Sanjit Jolly

Author

Sanjit Jolly
UNIVERSAL trial: Ultrasound-guided femoral access in patients with vascular closure devices

Modern management of PCI in complex lesions

18 May 2023 – From EuroPCR 2023

Watch Mirvat Alasnag, Ajay Kirtane and Flavio Ribichini as they talk modern PCI right in the middle of EuroPCR 2023.

They start by distinguishing between a complex patient and a complex lesion, and go on to define a complex PCI. Then they highlight the role of intracoronary...

Modern management of

What does TRILUMINATE Pivotal mean for my patients?

18 May 2023 – From EuroPCR 2023

Francesco Maisano joins Lars Sondergaard for a short but rich exchange of views on the TRILUMINATE Pivotal trial while EuroPCR 2023 is in full swing. This randomized trial, comparing TriClip versus medical treatment, was the first of its kind, and its initial outcomes are already very...

What does TRILUMINATE

Learnings and perspectives from the COAPT trial, 5-year follow-up

16 May 2023 – From EuroPCR 2023

Francesco Maisano and Lars Sondergaard meet up between 2 sessions of EuroPCR 2023 to discuss the 5-year results of the COAPT trial and share their key messages with us.

One of the main points to note is that 95 % of patients treated with MitraClip experiencing reduced...

Learnings and perspectives

Latest CoreValve Evolut platform’s clinical evidence: impact on current TAVI practice

17 May 2023 – From EuroPCR 2023

Watch this video in which Didier Tchétché, Nicolas Van Mieghem and Matthias Götberg were invited to talk about durability data, with special emphasis on the 5-year bioprosthetic valve dysfunction (BVD) data presented during EuroPCR 2023.

They begin by recalling what bioprosthetic valve dysfunction is, and how it...

Latest CoreValve Evolut

How to anticipate, plan and perform a TAV-in-TAV?

25 Jan 2024 – From PCR London Valves 2023

By 2023, although TAVI has become a safe routine procedure, it is now its long-term durability and the planning of a second procedure, particularly in younger patients, that is causing concern.

Vinayak Bapat and Bernard Prendergast discuss how to anticipate any potential TAV-in-TAV, take into account any...

How to anticipate, plan and perform a TAV-in-TAV?

Coronary imaging in the structural cathlab

21 Nov 2023 – From PCR London Valves 2023

If you still have any doubts, take a look at the presentations in this PCR LV 2023 session to be convinced of the importance of imaging, particularly IVUS, pre-, during and post-TAVI! It helps to prevent coronary artery occlusions, manage post-TAVR complications and guide rotablation, to name...

Coronary imaging in the structural cathlab

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

20 Nov 2023 – From PCR London Valves 2023

Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

Other cardiac interventions

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore innovative approaches to cardiac interventions featured at PCR Tokyo Valves 2023: from performing TricValve implantation in Asian patients to addressing unique cases like transcatheter valve replacement with a novel tricuspid bioprosthesis. Discover how these experts navigated challenging scenarios!

Didn’t find what you were looking for?